Volume 13
Issue 10
IEEE/CAA Journal of Automatica Sinica
| Citation: | W. Li, “A causal learning-based virtual population framework for chronic disease analysis,” IEEE/CAA J. Autom. Sinica, vol. 13, no. 10, pp. 2210–2221, Oct. 2026. doi: 10.1109/JAS.2026.126455 |
| [1] |
P. Sanchez, J. P. Voisey, T. Xia, H. I. Watson, A. Q. O’Neil, and S. A. Tsaftaris, “Causal machine learning for healthcare and precision medicine,” R. Soc. Open Sci., vol. 9, no. 8, Art. no. 220638, Aug. 2022. doi: 10.1098/rsos.220638
|
| [2] |
L. Xu, “An overview and perspectives on bidirectional intelligence: Lmser duality, double IA harmony, and causal computation,” IEEE/CAA J. Autom. Sinica, vol. 6, no. 4, pp. 865−893, Jul. 2019. doi: 10.1109/jas.2019.1911603
|
| [3] |
I. Bica, A. M. Alaa, C. Lambert, and M. van der Schaar, “From real-world patient data to individualized treatment effects using machine learning: Current and future methods to address underlying challenges,” Clin. Pharmacol. Ther., vol. 109, no. 1, pp. 87−100, Jan. 2021. doi: 10.1002/cpt.1907
|
| [4] |
D. K. Tobias, J. Merino, A. Ahmad, C. Aiken, J. L. Benham, D. Bodhini, A. L. Clark, K. Colclough, R.Corcoy, S. J. Cromer, et al., “Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine,” Nat. Med., vol. 29, no. 10, pp. 2438−2457, Oct. 2023. doi: 10.1038/s41591-023-02502-5
|
| [5] |
M. Prosperi, Y. Guo, M. Sperrin, J. S. Koopman, J. S. Min, X. He, S. Rich, M. Wang, I. E. Buchan, and J. Bian, “Causal inference and counterfactual prediction in machine learning for actionable healthcare,” Nat. Mach. Intell., vol. 2, no. 7, pp. 369−375, Jul. 2020. doi: 10.1038/s42256-020-0197-y
|
| [6] |
D. C. Whitcomb, “Primer on precision medicine for complex chronic disorders,” Clin. Transl. Gastroenterol., vol. 10, no. 7, Art. no. e00067, Jul. 2019. doi: 10.14309/ctg.0000000000000067
|
| [7] |
R. C. Wang and Z. Wang, “Precision medicine: Disease subtyping and tailored treatment,” Cancers, vol. 15, no. 15, Art. no. 3837, Jul. 2023. doi: 10.3390/cancers15153837
|
| [8] |
O. A. Carretero and S. Oparil, “Essential hypertension: Part I: Definition and etiology,” Circulation, vol. 101, no. 3, pp. 329−335, Jan. 2000. doi: 10.1161/01.CIR.101.3.329
|
| [9] |
D. G. Harrison, T. M. Coffman, and C. S. Wilcox, “Pathophysiology of hypertension: The mosaic theory and beyond,” Circ. Res., vol. 128, no. 7, pp. 847−863, Apr. 2021. doi: 10.1161/CIRCRESAHA.121.318082
|
| [10] |
J. Sundström, L. Lind, S. Nowrouzi, E. Hagström, C. Held, P. Lytsy, B. Neal, K. Marttala, and O. Östlund, “Heterogeneity in blood pressure response to 4 antihypertensive drugs: A randomized clinical trial,” JAMA, vol. 329, no. 14, pp. 1160−1169, Apr. 2023. doi: 10.1001/jama.2023.3322
|
| [11] |
S. Padmanabhan and A. F. Dominiczak, “Genomics of hypertension: The road to precision medicine,” Nat. Rev. Cardiol., vol. 18, no. 4, pp. 235−250, Apr. 2021. doi: 10.1038/s41569-020-00466-4
|
| [12] |
G. Parati, C. Lombardi, M. Pengo, G. Bilo, and J. E. Ochoa, “Current challenges for hypertension management: From better hypertension diagnosis to improved patients’ adherence and blood pressure control,” Int. J. Cardiol., vol. 331, pp. 262−269, May 2021. doi: 10.1016/j.ijcard.2021.01.070
|
| [13] |
T. J. Guzik, R. Nosalski, P. Maffia, and G. R. Drummond, “Immune and inflammatory mechanisms in hypertension,” Nat. Rev. Cardiol., vol. 21, no. 6, pp. 396−416, Jun. 2024. doi: 10.1038/s41569-023-00964-1
|
| [14] |
J. W. McEvoy, C. P. McCarthy, R. M. Bruno, S. Brouwers, M. D. Canavan, C. Ceconi, R. M. Christodorescu, S. S. Daskalopoulou, C. J. Ferro, E. Gerdts, et al., “2024 ESC guidelines for the management of elevated blood pressure and hypertension,” Eur. Heart J., vol. 45, no. 38, pp. 3912−4018, Oct. 2024. doi: 10.1093/eurheartj/ehae178
|
| [15] |
D. W. Jones, K. C. Ferdinand, S. J. Taler, H. M. Johnson, D. Shimbo, M. Abdalla, M. M. Altieri, N. Bansal, N. A. Bello, A. P. Bress, et al., “2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines,” Hypertension, vol. 82, no. 10, pp. e212−e316, Oct. 2025.
|
| [16] |
V. J. Dzau and C. P. Hodgkinson, “Precision hypertension,” Hypertension, vol. 81, no. 4, pp. 702−708, Apr. 2024. doi: 10.1161/HYPERTENSIONAHA.123.21710
|
| [17] |
S. Imran, T. Mahmood, A. Morshed, and T. Sellis, “Big data analytics in healthcare – A systematic literature review and roadmap for practical implementation,” IEEE/CAA J. Autom. Sinica, vol. 8, no. 1, pp. 1−22, Jan. 2021. doi: 10.1109/jas.2020.1003384
|
| [18] |
M. A. Gianfrancesco and N. D. Goldstein, “A narrative review on the validity of electronic health record-based research in epidemiology,” BMC Med. Res. Methodol., vol. 21, no. 1, Art. no. 234, Oct. 2021. doi: 10.1186/s12874-021-01416-5
|
| [19] |
B. Glocker, M. Musolesi, J. Richens, and C. Uhler, “Causality in digital medicine,” Nat. Commun., vol. 12, no. 1, Art. no. 5471, Sep. 2021.
|
| [20] |
K. Jiang, W. Liu, Y. Wang, L. Dong, and C. Sun, “Discovering latent variables for the tasks with confounders in multi-agent reinforcement learning,” IEEE/CAA J. Autom. Sinica, vol. 11, no. 7, pp. 1591−1604, Jul. 2024. doi: 10.1109/JAS.2024.124281
|
| [21] |
D. C. Aron, “Precision medicine and the challenges of human complexity,” Psychother. Psychosom., vol. 92, no. 6, pp. 349−353, Nov. 2023.
|
| [22] |
Å. Johansson, O. A. Andreassen, S. Brunak, P. W. Franks, H. Hedman, R. J. F. Loos, B. Meder, E. Melén, C. E. Wheelock, and B. Jacobsson, “Precision medicine in complex diseases-Molecular subgrouping for improved prediction and treatment stratification,” J. Intern. Med., vol. 294, no. 4, pp. 378−396, Oct. 2023. doi: 10.1111/joim.13640
|
| [23] |
A. Chaddad, Q. Lu, J. Li, Y. Katib, R. Kateb, C. Tanougast, A. Bouridane, and A. Abdulkadir, “Explainable, domain-adaptive, and federated artificial intelligence in medicine,” IEEE/CAA J. Autom. Sinica, vol. 10, no. 4, pp. 859−876, Apr. 2023. doi: 10.1109/JAS.2023.123123
|
| [24] |
S.-C. Lu, C. L. Swisher, C. Chung, D. Jaffray, and C. Sidey-Gibbons, “On the importance of interpretable machine learning predictions to inform clinical decision making in oncology,” Front. Oncol., vol. 13, Art. no. 1129380, Feb. 2023. doi: 10.3389/fonc.2023.1129380
|
| [25] |
A. S. Tang, S. R. Woldemariam, S. Miramontes, B. Norgeot, T. T. Oskotsky, and M. Sirota, “Harnessing EHR data for health research,” Nat. Med., vol. 30, no. 7, pp. 1847−1855, Jul. 2024. doi: 10.1038/s41591-024-03074-8
|
| [26] |
S. Zhou, Z. Xu, M. Zhang, C. Xu, Y. Guo, Z. Zhan, Y. Fang, S. Ding, J. Wang, K. Xu, et al., “Large language models for disease diagnosis: A scoping review,” NPJ Artif. Intell., vol. 1, no. 1, Art. no. 9, Jun. 2025. doi: 10.1038/s44387-025-00011-z
|
| [27] |
A. A. Armoundas, S. M. Narayan, D. K. Arnett, K. Spector-Bagdady, D. A. Bennett, L. A. Celi, et al., “Use of artificial intelligence in improving outcomes in heart disease: A scientific statement from the American Heart Association,” Circulation, vol. 149, no. 14, pp. e1028−e1050, Apr. 2024.
|
| [28] |
J. Abécassis, É. Dumas, J. Alberge, and G. Varoquaux, “From prediction to prescription: Machine learning and causal inference for the heterogeneous treatment effect,” Annu. Rev. Biomed. Data Sci., vol. 8, pp. 381−404, Aug. 2025. doi: 10.1146/annurev-biodatasci-103123-095750
|
| [29] |
S. Brouwers, I. Sudano, Y. Kokubo, and E. M. Sulaica, “Arterial hypertension,” Lancet, vol. 398, no. 10296, pp. 249−261, Jul. 2021. doi: 10.1016/S0140-6736(21)00221-X
|
| [30] |
R. J. Boffa, M. Constanti, C. N. Floyd, and A. S. Wierzbicki, “Hypertension in adults: Summary of updated NICE guidance,” BMJ, vol. 367, Art. no. l5310, Oct. 2019. doi: 10.1136/bmj.l5310
|
| [31] |
R. M. Touyz and E. L. Schiffrin, “A compendium on hypertension: New advances and future impact,” Circ. Res., vol. 128, no. 7, pp. 803−807, Apr. 2021. doi: 10.1161/CIRCRESAHA.121.319181
|
| [32] |
Z. Sun, W. Dong, J. Shi, and Z. Huang, “Interpretable disease progression prediction based on reinforcement reasoning over a knowledge graph,” IEEE Trans. Syst., Man, Cybern. Syst., vol. 54, no. 3, pp. 1948−1959, Mar. 2024. doi: 10.1109/TSMC.2023.3331847
|
| [33] |
J. Ge, Y. Xu, and C. Wang, Internal Medicine. 9th ed. Beijing, China: People’s Medical Publishing House, 2018.
|
| [34] |
A. E. W. Johnson, T. J. Pollard, L. Shen, L.-W. H. Lehman, M. Feng, M. Ghassemi, B. Moody, P. Szolovits, L. A. Celi, and R. G. Mark, “MIMIC-III, a freely accessible critical care database,” Sci. Data, vol. 3, Art. no. 160035, May 2016. doi: 10.1038/sdata.2016.35
|
| [35] |
L. McInnes, J. Healy, and J. Melville, “UMAP: Uniform manifold approximation and projection for dimension reduction,” arXiv preprint arXiv: 1802.03426, 2018.
|
| [36] |
S. Hong, H. He, P. Fang, S. Liu, and C. Chen, “Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular and all-cause mortality in hypertension patients,” Heliyon, vol. 10, no. 6, Art. no. e27517, Mar. 2024. doi: 10.1016/j.heliyon.2024.e27517
|
| [37] |
R. Xue, Q. Zhang, Q. Cao, R. Kong, X. Xiang, H. Liu, M. Feng, F. Wang, J. Cheng, Z. Li, et al., “Liver tumour immune microenvironment subtypes and neutrophil heterogeneity,” Nature, vol. 612, no. 7938, pp. 141−147, Dec. 2022. doi: 10.1038/s41586-022-05400-x
|
| [38] |
W. Li, W. Zhang, Q. Zhang, X. Zhang, and X. Wang, “Weakly supervised causal discovery based on fuzzy knowledge and complex data complementarity,” IEEE Trans. Fuzzy Syst., vol. 32, no. 12, pp. 7002−7014, Dec. 2024. doi: 10.1109/TFUZZ.2024.3471187
|
| [39] |
W. Li, Q. Zhang, and X. Wang, “Mechanisms under shifts: Interpretable clustering with self-improving heterogeneous causal graphs,” IEEE Trans. Pattern Anal. Mach. Intell., vol. 48, no. 8, pp. 10083−10096, Aug. 2026. doi: 10.1109/TPAMI.2026.3683072
|